Objectives: Recent studies have confinned the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an over expression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antagonist Meman tine-in patients with CRPS of one upper extremity. Here we present the results of 6 patients treated with Memantine for 8 weeks.
Methods: All patients developed CRPS after traumatic injury to one upper extremity. To document changes during the study, levels of pain were measured after clenching the hand using a numeric pain intensity scale ranging from 0 (no pain) to 10 (maximum pain). Motor symptoms were documented for the fingers (fingertips to palm and fingernails to table) and the wrist (flexion/extension). Furthennore, the force was analyzed using a JAMAR-Dynamometer and a Pinchmeter. For assessment of central changes, functional magnetic resonance imaging and magnetoencephalography were used to further document the results of other experiments in I patient. Autonomic changes were photographed and pictures were compared before and after treatment with Memantine.
Results: Six months after treatment with Memantine, all patients showed a significant decrease in their levels of pain which T he term "Complex Regional Pain Syndrome" (CRPS) describes a disorder previously known as "Sudeck's atrophy, causalgia or reflex sympathetic dystrophy.,,1 CRPS may develop after a traumatic injury or without any obvious triggering event.2,3 CRPS type I is distin guished from type II based on the criteria that a nerve lesion is documented in the latter. 4 Hence, in CRPS type II the nerve lesion leads to symptoms in the correspond ing anatomic projection area. 5 CRPS occurs mainly in the limbs and is characterized by pain, motor symptoms, sweating, edema, and autonomic changes of the skin (eg, hypertrichosis, abnormal sudomotor activity).6-8 These symptoms are defined as the classic diagnostic criteria for CRPS that were described in the 2nd ed. of the International Association for the Study of Pain (IASP) regarding the taxonomy of the disease. 9 Furthermore, a functional impairment of the affected extremity is frequently observed. The diagnosis is not only based on clinical signs and symptoms. Various diagnostic measurements can also be used (Table 1) to verify the disease.
1o CRPS usually progresses into a chronic disorder and chronic courses result in a low response to standard therapy.l1 The current treatment consists of noninvasive and invasive methods with limited effectiveness with the overall aim being the reduction of pain and restoration of function of the affected extremity.12 A combination of physiotherapy and the use of analgesic drugs is the usual standard treatment. [13] [14] [15] [16] For nonrespon ders, various invasive methods are recommended ranging from sympathetic blockade for sympathetically-induced symptoms to surgical sympathectomy.IO, 13, 17 In animal models used for the study of neuropathic pain syndromes, it has been proven that N-methyl-D aspartate (NMDA)-receptors are up-regulated in the central nervous system (CNS) and that blocking of these receptors reduces pain levels. 18 As CRPS is considered to be a neuropathic pain syndrome, we hypothesized that NMDA-receptors may be up-regulated in this case as well. Therefore, we treated the patients with the NMDA receptor antagonist Memantine. The use of Memantine in the therapy of CRPS has not yet, to our knowledge, been reported. Previous studies on the treatment of phantom limb pain with Memantine reported normalization of cortical reorganization: displaced or enlarged somatoto pic representation of the painful limb was successfully reversed after treatment. 19 ,20 There is increasing evidence that cortical reorganization is causally involved in the maintenance of chronic neuropathic pain. 21 ,22 .
The aim of this study was to demonstrate a CNS contribution in the development and preservation of CRPS. A pharmacologic intervention using the NMDA-receptor antagonist Memantine was hypothe sized to antagonize the central processes to improve the patients' condition.
MATERIAL AND METHODS

Patients
This study was conducted at the Department of Hand, Plastic, and Reconstructive Surgery, BG-Trauma Center at the University of Tuebingen, Germany. All patients were diagnosed with CRPS of one upper extremity according to the criteria of the IASP by the same investigator. The diagnosis was then confirmed or, if necessary, rejected by members of the other clinical investigation groups (Department of Anaesthesia and Psychiatry). Because all patients demonstrated a course with the classic signs and symptoms according to the IASP criteria no further diagnostic measures were needed to obtain the diagnosis. Informed consent was obtained from each patient, and the study was approved by the Ethical Committee of the Medical Faculty of the University of Tuebingen. Physiotherapy was performed daily following a standardized regimen?3 Patients were treated 3 times a day over a course of 8 weeks. Each work out was about 45 minutes. The treatment included massage, friction, and traction techniques. The patients were actively and passively moved using the affected joints. Furthermore, they were given the opportunity for voluntary physiotherapy with special soft balls to exercise finger movement. Individually developed dynamic splints were used to passively press the affected joints into wider ranges of movement and various proprioceptive measures were applicated as well (glass of peas, etc.).
Autonomic changes were documented before Mem antine intake by means of photography. After periods of 8 weeks, and 6 months after treatment, the patients were photographed and the changes were documented again.
Pharmacotherapy
Memantine is a low to moderate affinity, noncom petitive NMDA receptor antagonist, acting directly on the phencyclidine recognition site of the NMDA-receptor channel. It has been marketed in Germany since 1982, initially for the treatment of CNS diseases (Parkinson disease, cerebral and peripheral spasticity, Alzheimer disease, etc.). Because some of the patients were previously on analgesic drug therapy these drugs were discontinued to have the same conditions for all patients. Following this, a general treatment regimen with MST (Morphine) was initiated for a period of 2 weeks before Memantine treatment in an equianalgetic dose for all patients. After this dose was reached the 2 weeks of MST intake served as a baseline using a very potent analgesic drug as a control for comparison to the following Memantine treatment. Afterward, Memantine was pre scribed orally with 5 mg per day and increasing doses every second day (5 mg steps). A final target dose of 30 mg/d was defined and was applicated twice a day (15 mg/morning and 15 mg/evening). After arriving at the dose of 30 mg/d without any serious side effects, further increase of the daily intake was possible. Memantine was given for 8 weeks.
Pain
The patients were instructed to rate their pain on a numeric pain intensity scale (o--no pain, 1000maximum pain) after active clenching of the hand (5 times). Data was recorded before the application of Memantine, and at 8 weeks and 6 months after Memantine treatment.
Motor Symptoms
Motor function was elected as a target parameter to document a possible improvement of symptoms induced by CRPS treatment, because kinematic studies of target reaching and grip force analysis demonstrated pathologic sensorimotor integration in the parietal cortex in affected patients?4 Consequently, finger and wrist movement may be impaired in many cases. The finger and wrist joints are known to be excellent parameters for assessment of hand function, and were, therefore, defined as the joints of interest for measuring flexion and extension. 25 Motor symptoms were documented before Memantine treat ment, and after 8 weeks and 6 months after that. Finger movements were assessed using 2 different tests as follows: the patients were asked to make a fist. Incomplete fists were documented taking note of the distance between the fingertip of the impaired finger and the palm in centimeters. The same was done with the extension of the fingers while the patient had the back of his hand lying on the table. Impaired finger extension was noted with the distance between the fingernail and the underlying surface of the table in centimeters as wel1. 26 If more than one finger was impaired, the deficits of the affected fingers (for flexion or extension) were summed up to one value. Furthermore, the active range of wrist motion was measured with a goniometer for extension and flexion, whereas force was estimated by means of a computerized dynamometer. The patients had to push a JAMAR-dynamometer with their hand until the maximum strength was reached at level 2 of the dynamometer scale. To evaluate the strength of the pinch maneuver a computer-linked pad (3 x 3cm) was placed between the thumb and index finger. The data for both tests were recorded using Biometrics software (Penny and Gilles, Munich/Germany). All data regarding force were expressed in kilograms and compared with that obtained for the unaffected side as usually formulated for data evaluation?7,28
Magnetoencephalography and fMRI
Magnetoencephalography (MEG) was used to study changes in the cortical organization of the primary somatosensory cortex (Sl). For assessment of cortical activity, somatosensory evoked fields were recorded using a whole head magnetoencephalographic (MEG) system (CTF, Inc, Vancouver, Canada) with 151 first-order gradiometers. Sensory evoked fields were obtained by pneumatic stimulation (trials: 400, stimulus duration: 100 ms; interstimulus interval: 500 ms ± 50 ms, sampling rate: 612.5 Hz) of the thumb and little finger on the affected and the unaffected side, before and after treatment. The functional organization of S1 was determined by dipole analysis of the first prominent peak of the magnetic brain response. The localization was represented in a 3 dimensional grid and was expressed as the angle "9" between Cz and a direct line from the middle of the sphere to the dipole localization. 29 Cortical reorganization was expressed as the difference between the 9 angle of the cortical distance DI/DV of the affected side mirrored in the unaffected side in S1.
Due to the technical effort required only 1 patient underwent MRI scanning in a supine position at 3T (Siemens Trio, 8 HF-head-coil) with 30 oblique transver sal slices (3 mm thickness, 1mm gap) covering the whole head using a T2*-weighted echo-planar imaging sequence (TR = 2.5 s, matrix size = 64*64, TE = 30 ms, flip an gle = 90 degrees). The patient was in supine position on the padded scanner couch and wearing hearing protection while scanned. Additionally, a Tl weighted 3D image (MPrage; TR 2.3 s; TE: 3.93 ms; 160 sagittal slices 1+ 0.5 mm) was acquired.
Spatial preprocessing and data analysis were per formed using SPM2 (http://www.fil.ion.ucl.ac.uk/spm/ spm2.html). Each time-series was realigned and resliced after unwarping in phase encoding direction (anterior/ posterior) to account for susceptibility in mesolimbic areas and movement artifacts. Images were normalized to the MNI-reference to provide normalized location of activation maxima and to compare the premeasurement and postmeasurement within the same voxel space. To correct for intensity inhomogenities echo-planar imagings were smoothed with a Gaussian filter of 9mm (FWHM).
A design matrix for executed movements after minus before treatment was calculated using a high-pass filter of 128 seconds. Significant activation sites are given for areas of P < 0.001, after correction for false-positive responses within the whole brain volume (FWE).
The patient was tested before and 8 weeks after treatment with Memantine. Blood oxygenation level dependent response was recorded during fist clenching movements, in a block design (6 blocks, rest), first with the affected limb, and then with the unaffected limb. To control for equal hand-grip strength, the patients pressed a rubber ball of a vigorimeter.
Statistical Analysis
Data regarding levels of pain and motor symptoms were analyzed with analysis of variances (ANOVAs). For expected values, 95% confidence intervals (CIs) were computed.
The pain values of the 6 patients were assessed 3 times on a pain intensity scale (before Memantine treatment, and 8 wk and 6 mo after treatment with Memantine). These data were analyzed by the factors time and Memantine treatment (8 wk/6 mo).
To analyze the effect of treatment on finger move ment, data recorded for the fingertips to palm task (after clenching a fist and moving the fingernails to the table while extending the fingers) were used in 2 ANOVAs with the same factors as mentioned above. With a similar set of ANOVAs, we estimated the effect of Memantine treat ment on the range of wrist movement (one for extension, and the other for flexion). One patient was excluded from the analysis of wrist movement, because he underwent an operative arthrodesis of the wrist (Table 2) .
Finally, 2 ANOVAs were performed to analyze the data on the augmentation of force as measured using the dynamometer and pinch-meter. Data collected from the functional magnetic resonance imaging (fMRI) and MEG measurements are expressed as means and standard deviations. All ANOVAs were calculated based on the 2 factors patient and time.
RESULTS
Four men and 2 women (age range 29 to 64y; mean age 48.3 y) with CRPS were included in this study Table 2 . All patients underwent physiotherapy before their first visit in our clinic. The total time of physiotherapy performed is depicted in Table 2 . Patient No.3 was the only case with CRPS type II, whereas all the other patients had type 1. Due to the small number of patients, the prevalence of CRPS type II in this sample population, with regard to the ratio of type I versus type II, did not represent the data described in normal populations. 2 Six months after treatment with Memantine 5 of the 6 patients were able to return to their jobs without impairment, although under some circum stances, demonstrating only minor disabilities. Patient 4 had to leave her old profession in a bakery and successfully started a new job in an office. Patient 2 stopped the Memantine-intake after the study, whereas the other patients continue to take Memantine on their own request in the same fashion as they received it during the study.
Pain levels
No continuous pain was evident in any of the participating patients 6 months after treatment. To analyze the influence of Memantine on pain after clenching of the affected hand (5 times) 6 patients were examined at the three assessment dates using a numeric pain intensity scale (0 to 10). The effect of time after Memantine treatment at the assessment dates had a P value of less than 0.0001 (F-ratio: 286.95). The least square means of the levels of pain were 9.17 immediately before treatment with a 95% CI ranging from 8.55 to 9.78. After 8 weeks of Memantine application pain levels decreased on the numeric pain intensity scale to a score of 1.00 (95% CI: 0.39-1.61). Six months after treatment with Memantine the average level was 1.17 (95% CI: 0.55-1.78) (Fig. 1) .
Motor Symptoms
Range of finger motion was clearly different over the course of the 3 different assessments. The P value for the fingertips to palm task was smaller than 0. (Fig. 3) .
Drug Induced Side Effects
During the whole observation period no serious side effects were observed. One patient who was known to have Diabetes Mellitus observed slightly decreased blood sugar level values. Another patient reported cognitive problems with difficulties in concentration after increasing the daily Memantine-dose from 30 to 40 mg. The symptomsdisappeared after the dose was reduced to 30 mg.
DISCUSSION
The present data support the hypothesis of CNS involvement in the pathogenesis and maintenance of CRPS type I. Normalization of cortical reorganization after treatment with Memantine, as evidenced by fMRI and MEG was observed in the one exemplary patient after treatment with Memantine. The involved cortical areas clearly demonstrated abnormal activity before Memantine treatment. After 8 weeks of treatment these abnormalities were shown to decrease to a value comparable to the corresponding cortical sites of the unaffected limb.
Recently, it has been shown that there is an increased density of NMDA-receptors in the CNS of animals with neuropathic pain syndromes.
3o At present, the mechanism leading to the overexpression of these receptors remains unclear, and whether it plays a role in the pathogenesis of CRPS remains to be determined.
!
NMDA-receptor up-regulation may occur secondary to CRPS-related changes in cortical function. As a non competitive antagonist of NMDA-receptor activation under physiologic conditions, Memantine is hypothesized to leave the receptor with a mild depolarization, still allowing its physiologic activation. 32 With pathologic activation of the NMDA-receptors-as in CRPS-Meman tine is capable of a tonic blockade of these receptors. 33 Under these circumstances, Memantine is supposed to have a "neuroprotective" effect. 34 A possible NMDA receptor up-regulation in CRPS may not be a specific issue of this disease, nevertheless may be of importance in other neuropathic pain syndromes, for example, in phantom limb pain.
Patient No. 1 demonstrated, as evidenced through fMRI and MEG, cortical reorganization in areas representing the affected limb in comparison to the unaffected limb before Memantine treatment. With cortical normalization, a clinical improvement of the observed signs and symptoms was also found in this patient (see Results). There was a clear decrease in the level of pain measured with the numeric pain intensity scale from the time before therapy to 8 weeks, and 6 months, after Memantine treatment. Although only a few cases are presented in this report, the reduction in the levels of pain is significant. Moreover, the functional results demonstrate an impressive improvement in the range of motion after Memantine-treatment with increas ing values for wrist and finger movement. Even the strength increased 6 months after Memantine application as estimated by the JAMAR-dynamometer and the pinchmeter. The results obtained for the motor symptoms document the clinical benefit. These excellent functional results and the reduction of pain lead to the successful return of all patients but one to their old profession. Furthermore, all of these patients demonstrated a prominent amelioration of the autonomic symptoms.
Reviewing these initial results of six patients suffering from CRPS, one is tempted to speculate that the treatment of CRPS with Memantine may constitute a highly efficient treatment leading to normal hand function and decreased levels of pain. However, no control group undergoing physiotherapy and "activity of daily life" alone without pharmacologic intervention was used. The exercises with various dynamic splints to improve active and passive range of movement may itself playa significant role in improvement. Therefore, Memantine alone may not be responsible for these results. However, this is extremely unlikely because in the more than 100 patients that are treated with CRPS of the hand per year in our clinic none of them showed comparable recovery with physiotherapy and standardized treatment alone. Though it still remains difficult to conclude a clinical benefit based on a therapy with Memantine because all patients received this kind of pharmacologic treatment.
Another problem seems to be the small number of cases, which does not provide the possibility for further statistical analyses. Furthermore, only one patient in our study presented with CRPS type II, which represents a fraction of 17% of the examined individuals. In normal clinical practice we observe a ratio between 30% and 60% of CRPS type II cases, originating from various nerve injuries, respectively (cut injuries, compression syndromes, etc.).
In general, it seems that patients treated with Memantine participated with higher motivation in their daily physiotherapy sessions without restrictions due to pain. Thus, they performed their exercises consistently. Nevertheless, other strategies have been proposed in the past to break through the circle of pain before long lasting stiffness and atrophy develops in the affected limb. 35 ,36 Invasive measures such as sympathetic blockade of the upper limb are still a common treatment option in nonresponding cases. 3 ? Leaving the upper limb without proprioception due to this measure, however, may lead to an unintended side effect of partial or even complete paralysis which disturbs physiotherapeutic treatment. 38 Therefore, it should be an overall aim to avoid invasive measures in treating patients in this condition.
To conclude, our preliminary results gathered on 6 patients with CRPS of one upper extremity treated with Memantine support the hypothesis that cortical reorga nization is involved in the disease process. Furthermore, the data demonstrate a substantial clinical improvement with the use of pharmacologic measures that antagonize these cortical changes in the CNS. However, the lack of a suitable control group precludes the drawing of firm conclusions. Early Diagnosis in Post-traumatic Complex Regional P;
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Complex regional pain syndrome is characterized by the presence of regional pain and ser changes following a predominantly traumatic noxious event.
• 
INewsWireJ
'-,~---------~,."
. . :.lOO9
Complex regional pain syndrome is a severe complication in orthopedic surgery. Trauma patients; undergoing orthopedic procedures frequently develop complex regional pain syndrome, particularl~ the hand or forearm. It is characterized by the presence of regional pain and sensory changes folic predominantly traumatic noxious event. Pain is associated with abnormal skin color, skin temperat abnormal sudomotor activity, and edema. Two types of complex regional pain syndrome can be di formerly termed "reflex sympathetic dystrophy," occurs without a definable nerve lesion, whereas t termed "causalgia," refers to cases where a definable nerve lesion is present. 1 The diagnosis of complex regional pain syndrome is predominantly based on clinical signs and syr laboratory tests or imaging procedures have been applied in complex regional pain syndrome. Ho\ of tests have not been evaluated with regard to their sensitivity (ie, the probability that a patient ha' regional pain syndrome will have a positive test result) and specificity (ie, the probability that a pati complex regional pain syndrome will have a negative test result). No consensus exists on the crite complex regional pain syndrome or reflex sympathetic dystrophy and even with the new definitions regional pain syndrome, interobserver reliability and specifity is still poor and depends on the criter
Another important limitation is a consequence of the progressive nature of complex regional pain s stages, edema and increased skin temperature may be observed, whereas in later stages signs of dysregulation decrease but pain may persist. Diagnostic tests useful in early stages of the disease fail. Furthermore, signs and symptoms may change quickly. As a result, in many studies correlatiol findings, stage of the disease, and laboratory tests are not reported. Combined, these limitations ir determination of the diagnostic value of different test procedures used in complex regional pain sYI Nevertheless, it is important to establish an early diagnosis if it appears after trauma or surgery. Tt an overview of the clinical implications of tests and procedures in diagnosing complex regional pail
Clinical Signs and Symptoms
Since complex regional pain syndrome is a clinical diagnosis, the appearance of a typical constell~ is fundamental for establishing the diagnosis. In 1995 the definition of complex regional pain syndr evaluated by a Consensus Committee. A few years later, advanced diagnostic criteria were pUblisl clinical diagnosis. 1 ,2 The criteria of clinical symptoms are shown in Tables 1 and 2 . Inter-rater reliability is poor in the clinical diagnosis of complex regional pain syndrome and clinical difficult to evaluate; laboratory tests are helpful to verify the diagnosis. A hand volumeter can be u! edema by measuring the fluid overflow displaced by water comparing the healthy and diseased lilT
With motor disturbances, a goniometer is necessary to assess active or passive range of motion o' dynamometer and hand function questionnaires (eg, disability of arm, shoulder, hand or the Michi~ questionnaire) can register the degree of disability due to reduced hand function. 6 ,7 Measurements can be performed using a visual analog scale. s
The assessment of temperature side differences in complex syndrome is mandatory for establishing the diagnosis and c; with an infrared thermometer at different measuring points 0 thermal imaging. However, the dynamic character of this phi (depending on disease duration and environmental factors) into account.
While in healthy patients only slight differences in skin temp, sides have been documented (hands, 0.24±O.23°C; fingers. patients after hand or wrist trauma without any complication O.9°C±O.8°C were reported up to 8 weeks after trauma. 9 • 10 II complex regional pain syndrome, side-to-side temperature c C, O.6°C, or 1°C have been observed indicating high statistil substantial overlap with trauma patients lacking complex re~ syndrome: a useful diagnostic threshold should be set at a s 1.5°C to differentiate between normal physiological post-tral Other clinical findings include sensory impairment that can t "positive" (ie, allodynia, mechanical, and thermal hyperalges "negative" (ie, hypesthesia, hypalgesia) sensory findings ani observed in a localized (ie, glove-like) and generalized (ie, U hemisensory) distribution. 14 Quantitative sensory testing to c findings of sensory abnormalities was applied; however, the specific for complex regional pain syndrome and do not deli' additional diagnostic information. This method is not recomr routine laboratory test for the diagnosis of complex regional
Sympathetic Function Tests
Numerous studies revealed evidence for malfunction of the' nervous system in patients with complex regional pain syndl interpretation of these findings is controversial, the existenCt disturbances, particularly in the early phase of complex regi\ syndrome, is unquestionable. This phenomenon can be ass ways, leading to different diagnostic procedures with variom approaches.
The peripheral vasoconstrictor reflex, mediated by P-adrenergic sympathetic fibers, can be assess, Doppler f10wmetry or thermography using different stimuli (whole body warming, arousal maneuve sweating, qualitative methods exist that visualize the sweat response, or indirect methods like the I potentials (sympathetic skin response) can be applied. 15 Alternatively, sweat output can be quantif measurement. Local sweating can be induced through an axon reflex (quantitative sudomotor axol peripheral stimulation). The resting sweat output as well as the sweating induced by raised body te (thermoregulatory sweating, thermoregulatory sweat testing, central stimulation) can be recorded. 1
While vasoconstrictor actiVity is lowered in complex regional pain syndrome, sudomotor function is (resting sweat output) or enhanced (thermoregulatory sweat testing, quantitative sudomotor axon I Laboratory tests described are a useful diagnostic tool for complex regional pain syndrome; howe\ difficult to conduct and none could reach clinical importance due to the lack of standardization and
Neurophysiological Tests
The diagnosis of complex regional pain syndrome type I excludes-by definition-the presence of pl lesion and therefore nerve conduction velocity abnormalities are not expected. However, the diagn regional pain syndrome type II requires a peripheral nerve lesion and complex regional pain syndn following central nervous lesions, eg, brain infarction or brain tumors. Since signs and symptoms c pain syndrome I and II may be very similar, neurophysiological testing is important in differential di complex regional pain syndrome to confirm or to exclude major peripheral nerve or central nervow
With respect to nerve conduction velocity testing, discrete abnormalities on nerve conduction veloc observed due to edema or peripheral vasoconstriction. 15 ,2o Distinct abnormalities >20% of normal • noted and may indicate underlying peripheral nerve lesion, eg, carpal tunnel syndrome or complex syndrome II. Electromyography recordings were not routinely applied in clinical studies in complex syndrome patients because electromyography is painful and may worsen complex regional pain S)
With respect to somatosensory-evoked potentials after median/ulnar or tibial nerve stimulation in c pain syndrome I patients, somatosensory-evoked potentials reveal normal results in the majority 01 few patients borderline delay of latencies or amplitudes. In patients with suspected complex region II (severe trauma, localized sensory, or motor abnormalities consistent with peripheral nerve or rae somatosensory-evoked potentials may be pathological. Particularly in complex regional pain syndr proximal nerve lesions and in patients with possible central nervous system pathology, somatosen potentials may be helpful, as proximal nerve or central nervous system lesions cannot be detected conduction velocity measurements.
In complex regional pain syndrome patients with signs of central nervous system dysfunction, eg, I deficits or dystonia, somatosensory-evoked potentials recordings may be useful. Normal results inl abnormalities may be due to functional neuroplastic changes and further diagnostic procedures (ie resonance imaging [MRI] of the brain or spinal cord, lumbar puncture) are only required if the clinic structural central nervous system lesions. 14 Neurophysiological tests are useful in the differential diagnosis of complex regional pain syndrome a peripheral nerve or central nervous system lesion; however, the findings are not specific for the (
Assessment of Inflammatory Parameters
As first described by Sudeck,27 clinical symptoms of complex regional pain syndrome reveal simila inflammatory reaction. Within the past few years, several studies on arterial blood flow, oxygen utiI flux in complex regional pain syndrome as well as spectroscopic and scintigraphic studies were co supported the hypothesis that an exaggerated inflammatory response may play an important role f regional pain syndrome. However, the laboratory abnormalities observed in these studies were noi for complex regional pain syndrome. Thus the tests applied were predominantly of scientific intere:
For clinical purposes, it is important to distinguish complex regional pain syndrome from a local lim osteomyelitis, erysipel) that may have similar clinical findings. Laboratory tests in complex regional show parameters that mediate a systemic inflammatory response (C-reactive protein, erythrocyte l leukocyte count) are not elevated in complex regional pain syndrome whereas neuroinflammatory substance P, bradykinin, and calcitonin gene-related peptide were increased compared to healthy finding also supports the assumption of a localized inflammatory response that might be triggered mechanism. For differential diagnosis, this important finding points out that in patients with sympto regional pain syndrome but increased findings of generalized inflammation (erythrocyte sedimenta reactive protein, and leukocytes increased), other causes of inflammation should be excluded (Tat 
Imaging Methods
Radiography
Since Sudeck 27 described the typical radiographic changes on plain radiographs of the affected extremities, conventional bilateral radiographs of the hand are standard for diagnosing complex regional pain syndrome. The primary radiographic manifestations are diffuse osteoporosis with a severe patchy demineralization, especially of the periarticular regions, combined with a subperiostal bone resorption (Figure 2 ). In the middle of the past century, several authors noted evidence of a radiographic progression paralleled to the clinical disease activity.28,29 Later, typical radiological findings in complex regional pain syndrome patients were supposed to be unspecific and to appear late during the course of the disease. Prospective studies about particular findings and their clinical relevance are rare.
Bickerstaff et al,3° who investigated radiographic changes in patients after Colles' fracture with and without complex regional pain syndrome interpreted the similarity of disuse demineralization and complex regional pain syndrome, related demineralization as an effect of a common pathogenesis. They found a more marked and prolonged bone loss in complex regional pain syndrome patients Figure 2 : Radiological findi compared to immobilized trauma patients. This bone loss occurs regional pain syndrome of 1 more markedly at trabecular bone but increased endosteal resorption of cortical bone is also a feature. The extreme loss of function in complex regional pain syndrome I accelerate the bone demineralization process.
By applying a semi-quantitative scoring system for classifying the demineralization findings in 274
Colles' fracture a positive predictive value of 83% was reported 7 weeks after trauma (sensitivity 8' 75%). The scoring system consisted of a combination of features that are apparent at sites of trabl These comprise a generalized loss of density, patchy radiotranslucencies, subchondral radiotransl loss of trabecular definition. 31 Our findings could not confirm these results in a study with similar dE radiological examiners who were blinded towards the clinical findings of the patients. This investigl high specificity of radiological findings 8 weeks after trauma, but a fair sensitivity of 36%, leading t< predictive value of 58% in 175 patients after distal radial fracture. This data showed a high number clinical symptoms of complex regional pain syndrome that did not expose the typical radiological fil underlined assumption is that radiographic changes appear late during the course of the disease a radiography does not qualify as a screening procedure. 32 ,
Three-phase Bone Scan
Three-phase bone scans have been used for three dec complex regional pain syndrome. In particular, Kozin et established the characteristic pattern of scintigraphic fir present in complex regional pain syndrome patients. A< flow into the affected limb combined with an increased I during the blood pool phase and an increased periarticl delayed static phase are supposed to be pathognomon regional pain syndrome ( Figure 3) .35 According to chan picture during the course of the disease, the scintigrapt SUbjected to changes that should provide useful inform; therapeutic effects. 36
Most of the published studies present data about retros patient popUlations that underwent three-phase bone Sf Figure 3 : Three-phase bone scan in examination. 37 ,38 Diffusely increased juxta-articular trac complex regional pain syndrome of the delayed images was found to be the most sensitive indi left hand. regional pain syndrome. In these studies only patients \ suspicion for complex regional pain syndrome were ex~ results are limited due to bias in patient selection. The prevalence of complex regional pain syndro aforementioned study populations did not reflect the actual incidence of the disease in an unselect patient population. 39
Prospective studies describing the diagnostic power of three-phase bone scan in complex regional are rare. Todorovic et al 40 investigated complex regional pain syndrome patients after trauma usin! bone scan and radiography and found a high sensitivity with a positive predictive value of 97% in e scintigrams, whereas the radiography reached a sensitivity of 73% and a positive predictive value results must be carefully interpreted because only patients with clinical suspicion for complex regie syndrome were examined (n=20). The control group consisted of one patient.
Bickerstaff et a13 2 compared 16 patients with post-fracture complex regional pain syndrome to 6 pa fracture healing and found significantly elevated periarticular uptake in the complex regional pain s In our recent study 175 patients after distal radial fracture were prospectively followed for 4 month! bone scan was performed twice. Two blinded observers detected signs for complex regional pain! 16% of the clinically diagnosed complex regional pain syndrome patients 8 weeks after trauma. In sensitivity, a high specificity was found in the same study.
A meta-analysis of 19 articles relating three-phase bone scan to complex regional pain syndrome i extremity also revealed a poor sensitivity of approximately 50% of this diagnostic method. The sen phase bone scan decreases with the duration of the disease. 39 ,41 This observation suggests that ir the disease the characteristic changes in soft tissue and bone that lead to the pathological scintigr; normalize and are replaced by a centralization of the symptoms.
Three-phase bone scan appears to be a good diagnostic tool in non-trauma patients. For the early normal post-traumatic states and complex regional pain syndromes, this diagnostic method does r accuracy.
Magnetic Resonance Imaging
Since MRI allows visualization of soft-tissue and bone structure with high resolution, it has becomE in diagnosing various musculoskeletal disorders. Several authors suggested its application for dia~ regional pain syndrome I.
Magnetic resonance imaging examination in complex regional pain syndrome I patients revealed v that change during the course of the disease in a characteristic manner. 42 Skin thickening and bon changes in carpal and metacarpal bones as well as effusions of adjacent joints are supposed to bE acute and early phase of complex regional pain syndrome 1. 43 ,44 Magnetic resonance imaging is commonly performed with T1-and T2-weighted sequences and T1 sequences with fat suppression before and after intravenous administration of contrast material (gi Koch et al 45 questioned the diagnostic value of MRI in diagnosing complex regional pain syndromE among 17 clinically diagnosed complex regional pain syndrome I patients only 1 patient with typicc; Our data obtained in MRI investigation in 175 patients 8 and 16 weeks after distal radial fracture rE sensitivity of MRI that decreased from the 8th week to the 16th week investigation (43% to 14%) a specificity of 78% in the 8th week to 98% in the 16th week investigation. These results suggest the consequences of trauma or surgery mimic complex regional pain syndrome I-like MRI findings. In 1 complex regional pain syndrome disease patients often present without typical MRI findings. Thus useful screening method, but may be helpful in the exclusion of differential diagnoses.
Summary
Since prospective studies confirmed an incidence of >1 0% of complex regional pain syndrome cor patients after distal radial fracture, early diagnosis is important.3 2 . 46 Therapy should be commencet a systematic approach to avoid chronicity of the disease. Despite this, epidemiological studies reVl delay in effective treatment among complex regional pain syndrome patients, who were repeatedI) different physicians and often treated inadequately before being referred to specialized pain clinics In post-traumatic patients, the clinical examination still is preferred to establish the diagnosis of cor pain syndrome. First, possible differential diagnoses must be excluded. Next the clinical criteria of definition should be checked and documented, if possible with the help of verifying procedures. 1m could be applied; however, they are not useful for early diagnosis since sensitivity is low and the Cl trauma may interfere with potential complex regional pain syndrome findings. In questionable case examinations after short periods detect the presence of complex regional pain syndrome in orthop' particularly if symptoms are progressive or an expected improvement does not occur.
